The RGD sequence improves the binding of collagen IV-derived peptides to integrins: an in silico study

Document Type : Research Paper

Authors

1 Department of Biology, Yazd University, Yazd, Iran

2 Department of Fisheries, Faculty of Natural Resources, Urmia University, Urmia, Iran

Abstract

RGD-binding integrins are receptors overexpressed in various tumors and play an important role in their growth, angiogenesis and metastasis. Therefore, the design of inhibitors containing RGD has been of great interest to inhibit integrins and treat cancer. Arrestan, canstatin, and tumstatin, angiogenesis inhibitors derived from collagen IV, act by binding to integrins and inhibiting their signaling pathway. In a study, it was shown that peptides derived from arresten (A), canstatin (C), and tumstatin (T) are capable of inhibiting angiogenesis and tumor growth, and peptide C is more active than the other two peptides. In the present study, the RGD sequence was added to the end of the mentioned peptides and their structure was analyzed with the help of molecular dynamics simulation and their interaction with αvβ3, αvβ6, αvβ8, α5β1, and α6β1 integrins was analyzed using AutoDock 4 software. The results showed that the addition of RGD changes the secondary structures and reduces structural fluctuations in peptides. Also, peptides with RGD were bound to all integrins with a more negative binding energy, and the binding energy of the CRGD peptide was more negative than others. Therefore, RGD peptides can be suggested for further laboratory investigations. Overall, the results of this study can be useful for the design of integrin inhibitors to inhibit angiogenesis and tumor growth.

Keywords

Main Subjects


Articles in Press, Accepted Manuscript
Available Online from 11 April 2023
  • Receive Date: 09 December 2022
  • Revise Date: 03 March 2023
  • Accept Date: 13 March 2023